2nd International Conference and Expo on Parenterals & Injectables
Organization:
Conference Series LLC
Category:
Conference/Convention
Geographical Area:
Conferences & Conventions
Start
Date:
12/5/2016
End Date:
12/7/2016
Start Time:
09:00 AM
End Time:
04:00PM
Event
Info:
Parenterals 2016 is exclusively designed to relish the insightful advances and speeding innovations in the field of Parenterals and injectables. It is privileged with global, professional and influential excellences belonging to versatile domains of Parenterals arena. Parenterals-2016 mainly focuses on discussing the Innovative researches, manufacturing parameters, clinical strategies, risk management and consequences and regulatory challenges in drug design and discovery involving Parenterals. Parenterals conference-2016 provides a platform to critically analyze and understand the methods and mechanisms.
Parenterals 2016 can assuredly cohere the global ideologies of eminent researches with high-speed deft approach to its valuable participants. Track 1. Parenteral Drug Discovery Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. It involves Drug Discovery in Preclinical Research, Pharmacology in Drug Discovery, Innovative Drug Discovery and Nanotechnology, De-risking Drug Discovery, In Silico Approaches to Fragment-based Drug Design, Novel Approaches in Drug Discovery.
Track 2. Parenteral Drug Designing And Drug Development Drug design, sometimes referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of small molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modeling techniques. This type of modeling is often referred to as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the biomolecular target is known as structure-based drug design. .
DISCLAIMER: Our aim is to continuously provide our
progressive audience with an open and interactive medium to view
and share relevant,
beneficial and interesting "career, economic, lifestyle and
networking" listings, ads, content and resources.
While the above information may be accurate and viable, the role
of Minority Professional Network, Inc. (MPN) is
strictly as a communications medium, and we do not
accept any responsibility for
cancellation, changes, errors, omissions, inconveniences, or any other form
of liability for any content
displayed or disseminated via our web sites, or e-marketing or social media
promotional services.
If there are any
doubts, we
encourage you to conduct additional research or contact the listed host or responsible entity.
CLICK HERE to inform us about any ads, listings or content
which appear to be
inappropriate,
fraudulent or misleading, or inconsistent with our theme and focus.